Latest Breaking News On - Legend biotech - Page 21 : comparemela.com

Healthcare of Ontario Pension Plan Trust Fund Sells 99,800 Shares of Legend Biotech Co (NASDAQ:LEGN)

Healthcare of Ontario Pension Plan Trust Fund Sells 99,800 Shares of Legend Biotech Co (NASDAQ:LEGN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited statesPrudential plcFinancial services group incLegend biotech coInvesco ltdKorea investmentGoldman sachs groupSecurities exchange commissionLegend biotech corporationAtika capital managementLegend biotech company profileHealthcare of ontario pension plan trust fundOntario pension plan trust fundLegend biotechFree report

Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy

CARVYKTI® is the first CAR-T therapy for patients with relapsed and refractory multiple myeloma to receive a positive CHMP opinion for second line treatment .

New jerseyUnited statesYing huangEuropean medicines agencyAmerican society of clinical oncologyDrug administrationJapan ministry of healthJanssen biotech incMedicinal devices agencyCancer center clinica universidad de navarra spainCommittee for medicinal products human useCancer center clinica universidad de navarraLegend biotech corporationAmerican cancer societyExchange commission onEuropean commission

Legend Biotech Announces Positive CHMP Opinion for CARVYKTI (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy

23.02.2024 - Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended expansion of the CARVYKTI .

New jerseyUnited statesCancer center clinica universidad de navarraCancer center clinica universidad de navarra spainEuropean commissionLegend biotech corporation stockJapan ministry of healthExchange commission onAmerican cancer societyJanssen biotech incDrug administrationAmerican society of clinical oncologyMedicinal devices agencySan miguelSenior consultantRelease syndrome

J&J wins EU backing to expand labeling of CAR-T therapy (NYSE:JNJ)

J&J wins EU backing to expand labeling of CAR-T therapy (NYSE:JNJ)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

European medicines agencyEuropean commissionCommittee for medicinal products human useJanssen pharmaceuticalMedicinal productsHuman useLegend biotech

Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy

Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Committee for medicinal products human useEuropean commissionEuropean medicines agencyLegend biotechJanssen biotechMedicinal productsHuman use